Patient & HCP Communication Strategies

4 Creative Pharma Communication Strategies to Drive Engagement and Trust

The pharmaceutical and life sciences industry is evolving rapidly, but one challenge persists: how to communicate complex science clearly and creatively. In an era of omnichannel communication where patient-centricity is the cornerstone of trust and engagement, pharma companies must go beyond traditional formats to deliver content that resonates with healthcare professionals (HCPs), patients, caregivers, and…...
Read More

Top Stories

Nelson memo

The Nelson Memo: Igniting a Global Open Data

The landscape of scientific research is undergoing a seismic...
Rare diseases

Rare Diseases – An Evolving Medical

A disease is considered rare when it affects fewer than 1 in...

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
Patient & HCP Communication Strategies

4 Creative Pharma Communication Strategies to Drive Engagement and Trust

The pharmaceutical and life sciences industry is evolving rapidly, but one challenge persists: how to...
Heuristics in MedComms

Heuristics in Medical Communications: Boosting Impact Through Storytelling and Visual Design

Clarity and impact are everything in medical communications (MedComms). Whether you're crafting a compelling narrative...
ISMPP

21st Annual Meeting of ISMPP: A Summarized Report

The 21st Annual Meeting of ISMPP was held from May 12-14, 2025, in Washington, D.C...
MAPS EMEA 2025

Amplifying the Patient Voice: Reflections from MAPS EMEA 2025

At this year’s MAPS EMEA 2025 Annual Meeting in London, the message was clear: the...
Graphical or Visual Abstracts

Graphical Abstracts – Communicating Complex Information Visually

Three years ago, we explored how visual abstracts revolutionize research communication by transforming dense scientific findings into...
Rare diseases

Rare Diseases – An Evolving Medical Communications Landscape

A disease is considered rare when it affects fewer than 1 in 2,000 people. However...

Learn more ABOUT our company.